PDF herunterladen
Thorac Cardiovasc Surg 2022; 70(03): 217-232
DOI: 10.1055/s-0041-1726100
Review

Lobar versus Sublobar Resection in the Elderly for Early Lung Cancer: A Meta-Analysis

Josiah Ng   *
1   Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore
,
Yoshio Masuda   *
1   Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore
,
Jun Jie Ng
2   Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre Singapore, Singapore, Singapore
3   Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
,
Lowell Leow 
2   Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre Singapore, Singapore, Singapore
,
Andrew M. T. L. Choong
2   Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre Singapore, Singapore, Singapore
3   Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
4   Cardiovascular Research Institute, National University of Singapore, Singapore, Singapore
,
Harish Mithiran
2   Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre Singapore, Singapore, Singapore
› Institutsangaben
› Weitere Informationen
    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

Objectives We performed a systematic review and meta-analysis of outcomes of lobectomy versus sublobar resection in elderly patients (≥65) with stage 1 nonsmall cell lung carcinoma (NSCLC).

Methods We searched for relevant articles using a set of inclusion and exclusion criteria. Meta-analytic techniques were applied.

Results Twelve studies (n = 5834) were chosen. Our results indicate that in the elderly, lobectomy for stage 1 NSCLC confers a survival advantage over sublobar resection. Lobectomy patients had a lower risk of death within 5 years and lower odds of local cancer recurrence. Our results show that lobectomy had a better 5-year cancer-specific survival and 5-year disease-free survival that trended toward significance. The sublobar resection group showed better 30-day operative mortality that trended toward significance. Subgroup analysis of stage 1A cancer demonstrated no difference in 5-year overall survival rates. However, for stage 1B tumors 5-year overall survival favored lobectomy.

Conclusion Lobectomy for stage 1 NSCLC in elderly patients is superior to sublobar resection in terms of survival and cancer recurrence and should be afforded where possible. For stage 1A tumors, sublobar resection is noninferior and may be considered. Further randomized controlled trials in this topic is required.

Keywords

lobectomy - segmentectomy - lung cancer - elderly

Authors' Contribution

Joint first-authors Josiah Ng and Yoshio Masuda are medical students who contributed equally to the inception, discussion, and drafting of this paper. They have contributed equally to the registration, literature review, data extraction, data processing, and revision of the paper under the guidance of the senior authors. Their joint authorship is approved by the senior author.


* Joint first-authors.


Supplementary Material



Publikationsverlauf

Eingereicht: 10. Dezember 2020

Angenommen: 29. Januar 2021

Artikel online veröffentlicht:
01. Juni 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Torre LA, Siegel RL, Jemal A. Lung cancer statistics. In Lung Cancer and Personalized Medicine. Cham: Springer; 2016: 1-19
    Google Scholar
  • 2 Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest 2003; 123 (1, Suppl): 21S-49S
    CrossrefPubMedGoogle Scholar
  • 3 International Agency for Research on Cancer, World Health Organization. Lung Cancer Fact Sheet. https://gco.iarc.fr/today/data/factsheets/cancers/15-Lung-fact-sheet.pdf . Accessed February 21, 2021
    PubMedGoogle Scholar
  • 4 Ginsberg RJ, Rubinstein LV. Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 1995; 60 (03) 615-622 , discussion 622–623
    CrossrefPubMedGoogle Scholar
  • 5 Rami-Porta R, Tsuboi M. Sublobar resection for lung cancer. Eur Respir J 2009; 33 (02) 426-435
    CrossrefPubMedGoogle Scholar
  • 6 Blasberg JD, Pass HI, Donington JS. Sublobar resection: a movement from the Lung Cancer Study Group. J Thorac Oncol 2010; 5 (10) 1583-1593
    CrossrefPubMedGoogle Scholar
  • 7 Fan J, Wang L, Jiang GN, Gao W. Sublobectomy versus lobectomy for stage I non-small-cell lung cancer, a meta-analysis of published studies. Ann Surg Oncol 2012; 19 (02) 661-668
    CrossrefPubMedGoogle Scholar
  • 8 Altorki NK, Wang X, Wigle D. et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med 2018; 6 (12) 915-924
    CrossrefPubMedGoogle Scholar
  • 9 Nakamura K, Saji H, Nakajima R. et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol 2010; 40 (03) 271-274
    CrossrefPubMedGoogle Scholar
  • 10 Fiorelli A, Caronia FP, Daddi N. et al. Sublobar resection versus lobectomy for stage I non-small cell lung cancer: an appropriate choice in elderly patients?. Surg Today 2016; 46 (12) 1370-1382
    CrossrefPubMedGoogle Scholar
  • 11 Dell'Amore A, Monteverde M, Martucci N. et al. Lobar and sub-lobar lung resection in octogenarians with early stage non-small cell lung cancer: factors affecting surgical outcomes and long-term results. Gen Thorac Cardiovasc Surg 2015; 63 (04) 222-230
    CrossrefPubMedGoogle Scholar
  • 12 Laohathai S, Cho S, Yum S. et al. Clinical and functional outcomes after curative resection in octogenarians with clinical stage I non-small cell lung cancer. J Geriatr Oncol 2019; 10 (03) 436-438
    CrossrefPubMedGoogle Scholar
  • 13 Pawlak K, Gabryel P, Kujawska A. et al. Long-term results of surgical treatment of non-small cell lung cancer in patients over 75 years of age. Kardiochir Torakochirurgia Pol 2018; 15 (02) 65-71
    PubMedGoogle Scholar
  • 14 Okami J, Higashiyama M, Asamura H. et al; Japanese Joint Committee of Lung Cancer Registry. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol 2009; 4 (10) 1247-1253
    CrossrefPubMedGoogle Scholar
  • 15 Osaki T, Shirakusa T, Kodate M, Nakanishi R, Mitsudomi T, Ueda H. Surgical treatment of lung cancer in the octogenarian. Ann Thorac Surg 1994; 57 (01) 188-192 , discussion 192–193
    CrossrefPubMedGoogle Scholar
  • 16 PRISMA guidelines. http://www.prisma-statement.org/ . Accessed February 21, 2021
    PubMedGoogle Scholar
  • 17 PROSPERO. https://www.crd.york.ac.uk/PROSPERO/ . Accessed February 21, 2021
    PubMedGoogle Scholar
  • 18 Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev 2016; 5 (01) 210
    CrossrefPubMedGoogle Scholar
  • 19 Okada A, Hirono T, Watanabe T. Safety and prognosis of limited surgery for octogenarians with non-small-cell lung cancer. Gen Thorac Cardiovasc Surg 2012; 60 (02) 97-103
    CrossrefPubMedGoogle Scholar
  • 20 Lin L, Hu D, Zhong C, Zhao H. Safety and efficacy of thoracoscopic wedge resection for elderly high-risk patients with stage I peripheral non-small-cell lung cancer. Journal of cardiothoracic surgery 2013; 8 (01) 1-7
    PubMedGoogle Scholar
  • 21 Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007; 8 (01) 16
    CrossrefPubMedGoogle Scholar
  • 22 Razi SS, John MM, Sainathan S, Stavropoulos C. Sublobar resection is equivalent to lobectomy for T1a non–small cell lung cancer in the elderly: a Surveillance, Epidemiology, and End Results database analysis. Journal of Surgical Research 2016; 200 (02) 683-689
    CrossrefPubMedGoogle Scholar
  • 23 Cochrane Methods - University of Bristol Workshop. https://methods.cochrane.org/sites/methods.cochrane.org.cmi/files/public/uploads/Workshop%202%20slides.pdf . Accessed February 21, 2021
    PubMedGoogle Scholar
  • 24 Ikeda N, Hayashi A, Iwasaki K, Kajiwara N, Uchida O, Kato H. Surgical strategy for non–small cell lung cancer in octogenarians. Respirology 2007; 12 (05) 712-718
    CrossrefPubMedGoogle Scholar
  • 25 Vazirani J, Moraes J, Barnett S. et al. Outcomes following resection of non-small cell lung cancer in octogenarians. ANZ J Surg 2018; 88 (12) 1322-1327
    CrossrefPubMedGoogle Scholar
  • 26 Zhang Z, Feng H, Zhao H. et al. Sublobar resection is associated with better perioperative outcomes in elderly patients with clinical stage I non-small cell lung cancer: a multicenter retrospective cohort study. J Thorac Dis 2019; 11 (05) 1838-1848
    CrossrefPubMedGoogle Scholar
  • 27 Kilic A, Schuchert MJ, Pettiford BL. et al. Anatomic segmentectomy for stage I non-small cell lung cancer in the elderly. Ann Thorac Surg 2009; 87 (06) 1662-1666 , discussion 1667–1668
    CrossrefPubMedGoogle Scholar
  • 28 Qiu C, Wang G, Xu J. et al. Sublobectomy versus lobectomy for stage I non-small cell lung cancer in the elderly. Int J Surg 2017; 37: 1-7
    CrossrefPubMedGoogle Scholar
  • 29 Kadota K, Nitadori JI, Sima CS. et al. Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small stage I lung adenocarcinomas. J Thorac Oncol 2015; 10 (05) 806-814
    CrossrefPubMedGoogle Scholar
  • 30 Ujiie H, Kadota K, Chaft JE. et al. Solid predominant histologic subtype in resected stage I lung adenocarcinoma is an independent predictor of early, extrathoracic, multisite recurrence and of poor postrecurrence survival. J Clin Oncol 2015; 33 (26) 2877-2884
    CrossrefPubMedGoogle Scholar
  • 31 Dillman RO, Zusman DR, McClure SE. Surgical resection and long-term survival for octogenarians who undergo surgery for non-small-cell lung cancer. Clin Lung Cancer 2009; 10 (02) 130-134
    CrossrefPubMedGoogle Scholar
  • 32 Smith CB, Swanson SJ, Mhango G, Wisnivesky JP. Survival after segmentectomy and wedge resection in stage I non-small-cell lung cancer. J Thorac Oncol 2013; 8 (01) 73-78
    CrossrefPubMedGoogle Scholar
  • 33 Kent M, Landreneau R, Mandrekar S. et al. Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable patients. Ann Thorac Surg 2013; 96 (05) 1747-1754 , discussion 1754–1755
    CrossrefPubMedGoogle Scholar
  • 34 Altorki NK, Kamel MK, Narula N. et al. Anatomical segmentectomy and wedge resections are associated with comparable outcomes for patients with small cT1N0 non–small cell lung cancer. J Thorac Oncol 2016; 11 (11) 1984-1992
    CrossrefPubMedGoogle Scholar
  • 35 Suzuki K, Saji H, Aokage K. et al; West Japan Oncology Group, Japan Clinical Oncology Group. Comparison of pulmonary segmentectomy and lobectomy: safety results of a randomized trial. J Thorac Cardiovasc Surg 2019; 158 (03) 895-907
    CrossrefPubMedGoogle Scholar